참고문헌
- H.S. Park, H.J. Kim, M.J. Seol, D.R. Choi, E.C. Choi and J.H. Kwak, In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone. Antimicrob. Agents Chemother. 50, 2261 -2264 (2006). https://doi.org/10.1128/AAC.01407-05
- A.R. Kwon, Y.H. Min, J.M. Ryu, D.R. Choi, M.J. Shim and E.C. Choi, In vitro and in vivo activities of DW-224a a novel fluoroquinolone antibiotic agent. J. Antimicrob. Chemother. 58, 684 -688 (2006). https://doi.org/10.1093/jac/dkl304
- R.N. Jones, D.J. Biedenbach, P.G. Ambrose and M.A. Wikler, Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains. Diagn. Microbiol. Infect. Dis. 62, 110-112 (2008). https://doi.org/10.1016/j.diagmicrobio.2008.05.010
- J.M. Entenza, Y.A. Que, J. Vouillamoz, M.P. Glauser and P. Moreillon, Efficacies of moxifloxacin, ciprofloxacin and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrob. Agents Chemother. 45, 3076-3083 (2001). https://doi.org/10.1128/AAC.45.11.3076-3083.2001
- J. Han, J.C. Kim, M.K. Chung, B. Kim and D.R. Choi, Subacute toxicity and toxicokinetics of a new antibiotic, DW-224a, after single and 4-week repeated oral administration in dogs. Biol. Pharm. Bull. 26, 832-839 (2003) https://doi.org/10.1248/bpb.26.832
- D.C. Hooper, Mechanisms of action and resistance of older and newer quinolones. Clin. Infect. Dis. 31, S24-S28 (2000). https://doi.org/10.1086/314056
- M. Tanaka, T. Wang, Y. Onodera, Y. Uchida and K. Sato, Mechanisms of quinolone resistance in Staphylococcus aureus J. Infect. Chemother. 6, 131-139 (2000). https://doi.org/10.1007/s101560070010
- National Committee for Clinical Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard - Fifth Edition. Document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, PA. 11. (2000).
- F.J. Schmitz, M.E. Jones, B. Hofmann, B. Hansen, S. Scheuring, M. Luckefahr, A. Fluit, J. Verihoef, U. Hadding H.P. Heinz and K. Kohrer, Characterization of grlA, grlB, gyrA and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob. Agents Chemother. 42:1249-1252 (1998)
- H.J. Yun, Y.H. Min, Y.W. Jo, M.J. Shim and E.C. Choi, Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV. Int. J. Antimicrob. Agents 25:334-337 (2005) https://doi.org/10.1016/j.ijantimicag.2004.11.013